Related Experiment Videos
Characterisation of C5a receptor agonists from phage display libraries
Stuart A Cain1, Adrian Higginbottom, Peter N Monk
1Academic Neurology Unit, University of Sheffield Medical School, Sheffield S10 2RX, UK.
Biochemical Pharmacology
|October 18, 2003
Summary
Researchers engineered C5a des-Arg(74) variants using phage display to activate complement component 5a receptors (C5aR). These variants, particularly V3, demonstrate specific interactions with mutated C5aR, aiding in understanding ligand-receptor dynamics.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- C5a des-Arg(74) exhibits significantly lower receptor affinity and partial agonism compared to intact C5a.
- Phage display technology enables the isolation of protein variants with altered functional properties.
Purpose of the Study:
- To generate and characterize C5a des-Arg(74) variants with enhanced C5a receptor (C5aR) activation potency.
- To investigate the specific interactions between C5a variants and mutated C5aR to dissect ligand-receptor binding mechanisms.
Main Methods:
- Phage display selection was employed to isolate C5a des-Arg(74) variants from randomly mutated libraries.
- Functional analysis of isolated variants (V1-3) was performed using C5aR mutants, including Asp(282)Arg-C5aR and Arg(175)Ala/Asp-C5aR.
Main Results:
- Variant V2 and V3 demonstrated differential activation of Asp(282)Arg-C5aR, correlating with their C-terminal properties.
- V3 showed potent agonist activity at Asp(282)Arg-C5aR, suggesting specific interactions.
- Mutating Arg(175) in C5aR led to a loss of responsiveness to both C5a and C5a des-Arg(74), but V3 retained potency at these mutant receptors.
Conclusions:
- Engineered C5a des-Arg(74) variants can achieve C5aR activation potency comparable to intact C5a.
- The study highlights the utility of phage display-derived variants for elucidating specific ligand-receptor interactions and C5aR signaling pathways.